States limiting HIV drug access as federal funding plateaus

More than 20 states are actively reducing or considering cuts to funding for programs that help people access HIV medications as federal funding fails to keep pace with rising costs. Officials say slowing or halting state support could limit patient access to essential antiretroviral therapies and undermine progress in HIV treatment and prevention.

Policy makers argue that state budget constraints, competing priorities, and inflation-driven drug costs are driving the reversals or pauses in aid. Advocates warn that reduced state funding may disproportionately affect low-income and uninsured populations, potentially leading to higher long-term healthcare costs.

The development comes as federal funding levels plateau, prompting state health departments to reassess program sustainability and explore alternative financing or partnerships to maintain drug access for vulnerable residents.
Source and more information:
https://ift.tt/rcHpVwT